Clinical Drug Experience Knowledgebase

Acute Coronary Syndrome (Phase 3)

Acute Lung Injury (Phase 3)

Attention Deficit Disorder with Hyperactivity (Phase 3)

Cancer Pain (Phase 3)

Carcinoma, Non-Small-Cell Lung (Phase 2)

Coronavirus Infections (Phase 4)

Graft vs Host Disease (Phase 3)

Hyperhidrosis (Phase 3)

Infections (Phase 3)

Influenza, Human (Phase 3)

Lactose Intolerance (Phase 3)

Leukemia (Phase 3)

Leukemia, Lymphoid (Phase 3)

Leukemia, Myelogenous, Chronic, BCR-ABL Positive (Phase 3)

Leukemia, Myeloid (Phase 3)

Leukemia, Myeloid, Acute (Phase 3)

Leukemia, Myelomonocytic, Chronic (Phase 3)

Leukemia, Myelomonocytic, Juvenile (Phase 3)

Lung Neoplasms (Phase 2)

Migraine Disorders (Phase 3)

Musculoskeletal Pain (Phase 3)

Myelodysplastic Syndromes (Phase 3)

Myeloproliferative Disorders (Phase 3)

Neoplasm Metastasis (Phase 3)

Neoplasms (Phase 3)

Pneumonia (Phase 3)

Pneumonia, Viral (Phase 3)

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 3)

Preleukemia (Phase 3)

Respiratory Distress Syndrome (Phase 3)

Respiratory Distress Syndrome, Newborn (Phase 3)

Severe Acute Respiratory Syndrome (Phase 4)

Syndrome (Phase 3)

Venous Insufficiency (Phase 4)

Virus Diseases (Phase 3)